Republican senators John Cornyn and Chuck Grassley and Democratic Sen. Amy Klobuchar are rolling out a bipartisan measure to ...

Company Leverages More Than Twenty Years of Drug Response Data Derived from Massive Biobank of Live Cell Tumor ...

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of ...

Me's sale to Regeneron transfers genetic data for drug development, raising privacy issues and concerns over consumer control ...

North Carolinians have until July 14, 2025, to file claims against DNA testing company 23andMe. The claims can be for general ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.

There is nothing more inherently unique and personal to an individual than his or her DNA. Unlike many other types of personal information, a ...

Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...

In the latest episode of Touching Base, we discuss big news in CRISPR along with updates in the business side of biotech.

New Hampshire on Thursday became the first state in New England to ban so-called sanctuary cities. "There will be no ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...